Gene · 7305
Papers3,266
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,266
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis Reveals Prognostic and Therapeutic Immunity-Related Biomarkers for Pediatric Metastatic Osteosarcoma. | Medicina (Kaunas) | 2024 | 38256356 | PubTator, text mining | PubMed |
| The Importance of Complement-Mediated Immune Signaling in Alzheimer's Disease Pathogenesis. | Int J Mol Sci | 2024 | 38255891 | PubTator, text mining | PubMed |
| The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. | Cancers (Basel) | 2024 | 38254780 | PubTator, text mining | PubMed |
| miRNA profiling of esophageal adenocarcinoma using transcriptome analysis. | Cancer Biomark | 2024 | 38250763 | PubTator, text mining | PubMed |
| Breakthrough of solid tumor treatment: CAR-NK immunotherapy. | Cell Death Discov | 2024 | 38245520 | PubTator, text mining | PubMed |
| A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting. | Acta Neuropathol | 2024 | 38244079 | PubTator, text mining | PubMed |
| Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells. | Immunohorizons | 2024 | 38240638 | PubTator, text mining | PubMed |
| Function and mechanism of TREM2 in bacterial infection. | PLoS Pathog | 2024 | 38236825 | PubTator, text mining | PubMed |
| Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease. | PLoS One | 2024 | 38236817 | PubTator, text mining | PubMed |
| Characterization of the Immune Microenvironment and Identification of Biomarkers in Chronic Rhinosinusitis with Nasal Polyps Using Single-Cell RNA Sequencing and Transcriptome Analysis. | J Inflamm Res | 2024 | 38229690 | PubTator, text mining | PubMed |
| CEP55, serving as a diagnostic marker gene for osteosarcoma, triggers the JAK2-STAT3-MMPs axis. | Ann Med Surg (Lond) | 2024 | 38222763 | PubTator, text mining | PubMed |
| Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications. | Virol J | 2024 | 38216935 | PubTator, text mining | PubMed |
| Identification of important genes related to HVSMC proliferation and migration in graft restenosis based on WGCNA. | Sci Rep | 2024 | 38216708 | PubTator, text mining | PubMed |
| Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review. | Int J Mol Sci | 2024 | 38203802 | PubTator, text mining | PubMed |
| The Interaction of HMGB1 with the Proinflammatory TREM-1 Receptor Generates Cytotoxic Lymphocytes Active against HLA-Negative Tumor Cells. | Int J Mol Sci | 2024 | 38203798 | PubTator, text mining | PubMed |
| Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans. | J Clin Med | 2024 | 38202265 | PubTator, text mining | PubMed |
| Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer. | J Immunother Cancer | 2024 | 38199610 | PubTator, text mining | PubMed |
| Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. | Sci Rep | 2024 | 38184757 | PubTator, text mining | PubMed |
| Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma. | Cell Death Dis | 2024 | 38182561 | PubTator, text mining | PubMed |
| TYROBP as a molecular target in cholangiocarcinoma, renal cancer and abdominal aortic aneurysm. | Medicine (Baltimore) | 2024 | 38181271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7305/papers?page=10